ARCHIVES

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

Smokeless Tobacco Consensus Conference Slates in Health Risks

August 16, 1985

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997